Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124713363 | 12471336 | 3 | F | 201508 | 20160811 | 20160616 | 20160812 | PER | US-PFIZER INC-2016283425 | PFIZER | 64.00 | YR | F | Y | 61.00000 | KG | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124713363 | 12471336 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | STRENGTH 0.625 MG, INTRAVAGINALLY EVERY TWO TO THREE DAYS | L94896 | 20216 | VAGINAL CREAM | |||||||||
| 124713363 | 12471336 | 2 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | STRENGTH 0.625 MG, INTRAVAGINALLY EVERY TWO TO THREE DAYS | M14156 | 20216 | VAGINAL CREAM | |||||||||
| 124713363 | 12471336 | 3 | SS | PREMARIN | ESTROGENS, CONJUGATED | 1 | INTRAVAGINALLY EVERY TWO TO THREE DAYS | M14153 | 20216 | VAGINAL CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124713363 | 12471336 | 1 | Vulvovaginal burning sensation |
| 124713363 | 12471336 | 2 | Hormone replacement therapy |
| 124713363 | 12471336 | 3 | Endometrial disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124713363 | 12471336 | Drug ineffective | |
| 124713363 | 12471336 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |